Clinical trials: Radiotherapy-induced Nausea and Vomiting (RINV)
Radiotherapy-induced Nausea and Vomiting (RINV), Pediatric Cancer
Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
The goal of this study is to evaluate the antiemetic efficacy and drug safety of ondansetron orodispersible film in pediatric patients with malignant tumors who received moderate emetic risk radiation induced vomiting, and to…
- Trial name
- NCT07217600
- Testing
- Ondansetron orodispersible film once, Ondansetron orodispersible film twice
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Chongqing University Cancer Hospital
Radiotherapy-induced Nausea and Vomiting (RINV)
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
The purpose of this study is to explore the dose response of SyB D-0701 for preventing nausea and emesis associated with radiotherapy (fractionated/localized irradiation) in cancer patients scheduled to receive radiotherapy…
- Trial name
- NCT01700140
- Testing
- SyB D-0701
- Where
- 21 sites in Japan
- Volunteers
- 189 people
- Sponsor
- SymBio Pharmaceuticals
Nausea, Vomiting
The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
This study sought to investigate the efficacy and safety of a three-drug combination antiemetic regimen of olanzapine combined with aprepitant and palonosetron for the prevention of chemoradiotherapy-induced nausea and vomiting…
- Conditions
- Nausea, Vomiting, Head and Neck Squamous Cell Carcinoma, Radiotherapy Side Effect
- Trial name
- NCT05202275
- Testing
- Olanzapine
- Where
- China
- Volunteers
- 43 people
- Sponsor
- Chinese Academy of Medical Sciences
Nausea, Vomiting
Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV)
This phase II study will investigate the use of palonosetron in the efficacy of prophylaxis or rescue of single or multiple fraction radiation induced nausea and vomiting.
- Trial name
- NCT02388750
- Testing
- Palonosetron, Low or moderate risk radiotherapy
- Where
- Canada
- Volunteers
- 96 people
- Sponsor
- Dr. Edward Chow
Chemotherapy-Induced Nausea and Vomiting (CINV), Radiotherapy-induced Nausea and Vomiting (RINV)
A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults
A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults
- Conditions
- Chemotherapy-Induced Nausea and Vomiting (CINV), Radiotherapy-induced Nausea and Vomiting (RINV), Postoperative Nausea and Vomiting
- Trial name
- NCT07868861
- Testing
- NS003 Ondansetron HCl microspheres powder for nasal application, Ondansetron Solution for IV infusion 8mg
- Where
- Israel
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Nasus Pharma